1Losi ,Roncucci L ,Gregorio CD,et al . K-ras and p53 mutation in human eolorectal aberrant crypt foci[J]. J Pathol , 1996,17(8) :259- 263.
2Adjei AA. Blocking oncogenic Ras signaling for cancer therapy [ J] .J Natl Cancer Inst, 2001,93 (14) : 1062 - 1074.
3Kim CF,Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in nomlal lung and lung cancer [J]. Cell, 2005, 121 (6) :823 - 835.
4Pontieri-Lewis V. Colorectal cancer:prevention and screelfing[J]. Medsurg Nurs,2000,14(9) :9 - 13.
1Pontieri-Lewis V.Colorectal cancer: prevention and screening.Medsurg Nurs,2000,9:9-13,20:14-15.
2Stroun M,Anker P,Maurice P,et al.Neoplastic characteristics of the DNA found in the plasma of cancer patients.Oncology,1989,46:318-322.
3Magnac C,Sutton L,Cazin B,et al.Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL).Hematol Cell Ther,1999,41:13-18.
4Nawroz H,Koch W,Anker P,et al.Microsatellite alterations in serum DNA of head and neck cancer patients.Nat Med,1996,2:1035-1037.
5Su LK,Steinbach G,Sawyer JC,et al.Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis.Hum Genet,2000,106:101-107.
6Harkingham JE,Kotasek D,Sage RE. et al.Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease[].Molecular Medicine.1995
7Kopreski MS,Benko FA,Kwee C,et al.Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer[].Breast Cancer.1997
8Ahnen DJ,Feigl P,Quan G,et al.K-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study[].Cancer Research.1998
9Kinzler KW,Vogelstein B.Lessons from hereditary colorectal cancer[].Cell.1996
1Morgan S R,Whiteley J,Donald E,et al.Comparison of KRAS mutation assessment in tumor DNA and circulating free DNA in plasma and serum samples[J].Clin Med Insights Pathol,2012,5(1):15-22.
